| Tag |
First Indicator |
Second Indicator |
Subfields |
| LEADER |
00000cam a2200000Ka 4500 |
| 001 |
in00002731237 |
| 005 |
20210727160005.0 |
| 006 |
m d |
| 007 |
cr cn| |
| 008 |
111014s2011 nyua ob 001 0 eng d |
| 019 |
|
|
|a 756922687
|
| 020 |
|
|
|a 1461406501 (electronic bk.)
|
| 020 |
|
|
|a 9781461406501 (electronic bk.)
|
| 035 |
|
|
|a (OCoLC)756920777
|z (OCoLC)756922687
|
| 035 |
|
|
|a (OCoLC)ocn756920777
|
| 035 |
|
|
|a 3932585
|
| 037 |
|
|
|a 978-1-4614-0649-5
|b Springer
|n http://www.springerlink.com
|
| 040 |
|
|
|a GW5XE
|b eng
|c GW5XE
|d UtOrBLW
|
| 049 |
|
|
|a TXAC
|
| 050 |
|
4 |
|a RC632.S67
|b S64 2011
|
| 060 |
1 |
4 |
|a W1
|b AD559 v.721 2011
|
| 060 |
1 |
4 |
|a WD 200
|
| 082 |
0 |
4 |
|a 616.3/9
|2 23
|
| 245 |
0 |
0 |
|a Sphingolipids and metabolic disease /
|c edited by L. Ashley Cowart.
|
| 264 |
|
1 |
|a New York, N.Y. :
|b Springer Science+Business Media ;
|a Austin, Texas :
|b Landes Bioscience,
|c [2011]
|
| 264 |
|
4 |
|c ©2011
|
| 300 |
|
|
|a 1 online resource.
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 490 |
1 |
|
|a Advances in experimental medicine and biology ;
|v v. 721
|
| 500 |
|
|
|a Electronic resource.
|
| 504 |
|
|
|a Includes bibliographical references and index.
|
| 505 |
0 |
|
|a Sphingolipid metabolism and analysis in metabolic disease / Sarah E. Brice and L. Ashley Cowart -- Sphingolipids and cardiovascular diseases : lipoprotein metabolism, atherosclerosis and cardiomyopathy / Xian Cheng Jiang, Ira J. Goldberg, and Tae Sik Park -- Heart sphingolipids in health and disease / Marcin Baranowski and Jan Grski -- Blood sphingolipids in homeostasis and pathobiology / Samar M. Hammad -- Adipose tissue and ceramide biosynthesis in the pathogenesis of obesity / Fahumiya Samad ... [et al.] -- Sphingolipids and hepatic steatosis / Benjamin T. Bikman and Scott A. Summers -- Glycosphingolipids and insulin resistance / Johannes M. Aerts ... [et al.] -- Glycosphingolipids and kidney disease / Andrew R. Mather and Leah J. Siskind -- Sphingolipid synthetic pathways are major regulators of lipid homeostasis / Tilla S. Worgall.
|
| 588 |
|
|
|a Description based on print version record.
|
| 650 |
1 |
2 |
|a Metabolic Diseases
|x pathology.
|0 https://id.nlm.nih.gov/mesh/D008659Q000473
|
| 650 |
1 |
2 |
|a Sphingolipids
|x metabolism.
|0 https://id.nlm.nih.gov/mesh/D013107Q000378
|
| 650 |
|
0 |
|a Sphingolipidoses.
|0 http://id.loc.gov/authorities/subjects/sh85126605
|
| 650 |
|
0 |
|a Sphingolipids
|x Pathophysiology.
|
| 655 |
|
7 |
|a Electronic books.
|2 local
|
| 700 |
1 |
|
|a Cowart, Lauren Ashley.
|0 http://id.loc.gov/authorities/names/no2002106730
|
| 710 |
2 |
|
|a SpringerLink (Online service)
|0 http://id.loc.gov/authorities/names/no2005046756
|
| 776 |
0 |
8 |
|i Print version:
|t Sphingolipids and metabolic disease.
|d New York, N.Y. : Springer Science+Business Media ; Austin, Texas : Landes Bioscience, c2011
|z 9781461406495
|w (DLC) 2011021157
|w (OCoLC)727303204
|
| 830 |
|
0 |
|a Advances in experimental medicine and biology ;
|v v. 721.
|0 http://id.loc.gov/authorities/names/n42001229
|
| 856 |
4 |
0 |
|u http://proxy.library.tamu.edu/login?url=https://dx.doi.org/10.1007/978-1-4614-0650-1
|z Connect to the full text of this electronic book
|t 0
|
| 994 |
|
|
|a 92
|b TXA
|
| 999 |
|
|
|a MARS
|
| 999 |
f |
f |
|s f6382c2e-2fb1-311c-8a39-03ff9e8d39fd
|i 26f7b8bb-d0f8-34a2-9447-7399fb5210d8
|t 0
|
| 952 |
f |
f |
|a Texas A&M University
|b College Station
|c Electronic Resources
|d Available Online
|t 0
|e RC632.S67 S64 2011
|h Library of Congress classification
|
| 998 |
f |
f |
|a RC632.S67 S64 2011
|t 0
|l Available Online
|